A user experience of Idylla™, the mini-lab
Idylla™, Biocartis’ fully automated molecular diagnostics system was launched in September 2014. Since then, over 100 units have been sold. We asked the very first customer, Prof. dr. Bart Neyns to share his experience with our readers. “We bought the platform at the launch event, so we have had it from the very first day […]
MS slowly but surely unravels its secrets
Piet Stinissen is Professor and Dean at the Faculty of Medicine and Life Sciences at the University of Hasselt, where he is head of the Immunology and Biochemistry laboratory. He is a biochemist and obtained a PhD in molecular genetics in the lab of Christine Van Broeckhoven (UA). He is chairman of BIOMED (Biomedical Research […]
VolitionRx detects colon cancer with a drop of blood
Belgian Volition – a subsidiary of Volition Rx – is a life sciences company located in Namur (Belgium) focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions. By bringing together the ELISA diagnostic technology with cutting-edge nucleosome detection and analysis techniques, the start-up aims to revolutionize cancer detection. […]
Alzheimer’s can be predicted early
Koen Dewaele (CEO) started ADx about three and a half years ago, when Fujirebio (the former Innogenetics), cut back its research activities drastically. Four employees who already worked on Alzheimer’s biomarkers decided to continue the research and founded their own company. The company develops diagnostic tests to screen for Alzheimer’s.